| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 1.7K | 11.2% | 34.2% |
| Total Income | 1.7K | 11.2% | 33.6% |
| Expenditure | 1.5K | 12.1% | 35.9% |
| PBT | 232.77 | 6.1% | 21.0% |
| Net Profit | 173.36 | 4.9% | 15.1% |
| OPM | 15.22% | 0.76pp | 1.71pp |
| NPM | 10.04% | 0.60pp | 1.62pp |
| EPS | 4.29 | 4.9% | 15.0% |
Strong revenue growth offset by margin pressure and export softness
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met Q2 revenue and PAT targets. Prior guidance on capex and order book coverage reaffirmed. Margin recovery timeline not quantified; depends on commodity pass-through and customer acceptance.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong top-line growth (34.2% YoY) and market share gains are real, backed by ₹165K Cr order book covering FY2030 revenue. However, margin compression (OPM 15.2% vs EBITDA margin 17.2%) reflects commodity cost lag and non-indexed input pressures. Key risk: export orders declining ~50% YoY due to tariff uncertainty and Western market slowdown.
₹1718.3 Cr
Revenue · +34.2% YoY₹173.4 Cr
Reported PAT · +15.1% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue grew 34.2% YoY to ₹1,718 Cr
METDelivered ₹1,718.3 Cr, +34.2% YoY
Q2 PAT ₹173 Cr, +15% YoY
METDelivered ₹173.4 Cr, +15.1% YoY
Value-added revenue grew 32.2% YoY; volume +25.4%
METVAR growth stated; delivered shows 34.2% total revenue growth
H1 FY27 revenue ₹326 Cr, +27.2% YoY
METDelivered H1 aligns with growth trajectory
EBITDA margin 17.2% on VAR (Q2); 17.5% (H1)
OVERSTATEDOPM 15.2%, NPM 10.0% delivered; variance due to commodity pass-through lag
Order book ₹165,000 Cr covers >100% FY2030 revenue
UnverifiedStated but not audited; management notes double-digit growth trajectory through FY2030
Export order book ~50% of FY2030 export revenue target
UnverifiedStated; export actual revenue ~7% of Q2 total
Earnings quality
What changed since the last call
Order book disclosed
NewH1 FY27 lifetime order book ₹165,000 Cr, >100% of FY2030 revenue target. Exports ₹8,750 Cr (50% of FY2030 export revenue target). Prior call did not quantify; now a key visibility driver.
Export order book weakness
DowngradeExports accounted for <1.5% of H1 revenue despite ₹8,750 Cr order book (soft Western markets, tariff risk, GDP contraction). Prior guidance implied stronger export momentum.
Capacity expansion accelerated
UpgradeThree new plants announced (North, West, ART suspension). North India Clean Air ₹450 Cr, West India ₹450 Cr. Prior capex ₹350-450 Cr reaffirmed but deployment clarified.
Three-wheeler suspension segment entry
NewWon suspension business with Indo-Korean OEM. DaVinci technology entry into three-wheeler, expanding addressable market. New product-customer combo.
Margin recovery timeline uncertain
NeutralManagement confirms commodity headwind (oil, non-indexed items) but won't commit recovery timeline. Discussions with OEMs ongoing. Prior guidance vague on timing.
The Q&A
Analysts pressed on margin compression (Radha, Viraj), export order decline (Himanshu), and subsidiary ART profitability (Shubham). Management acknowledged commodity impact, tariff risk, and disclosed discussions with OEMs on pass-through. Held firm on order book strength and long-term growth but hedged on near-term margin recovery and export sustainability.
Margin compression Q2 — Radha, Motilal Oswal
PartialOil, steel, lube cost increases. Mostly non-indexed; discussing recovery with OEMs. Lag of quarter or so. Difficult to commit timeline; discussions ongoing.
Dividend policy — Radha, Motilal Oswal
DodgedHave dividend policy on website. Will decide timing based on capital allocation and investment needs. Good cash generation; exploring opportunities.
Export order book decline — Pradip Pandey, Axis Capital
AnsweredMarket softness in West. GDP contraction, vehicle delivery delays, China OEM competition, tariff uncertainty post-Trump. Some SOP launches delayed. No customer loss; strong domestic order book.
Clean Air margin outlook — Viraj Sanghvi, Ambit Capital
PartialCommodity pressure main driver. DaVinci and semi-active suspension will improve mix as volumes scale. Margin plateau likely as market matures and conventional suspended; DaVinci transition gradual.
FY2030 revenue target — Rajat Agarwal, Nilgiri Advisors
PartialOrder book coverage is the metric. ₹165K Cr order book covers FY2030 fully. We are confident of double-digit growth through FY2030. Not disclosing specific FY2030 number but order book visibility strong.
Capex deployment & payback — S.A. Narayan, Caprigun Research
AnsweredNorth India Clean Air SOP March 2027. West India Clean Air SOP Sept 2027. ART suspension SOP July 2027. ROCE ~94%. Payback 3-4x on gross block. Modular design allows high utilization as customer volumes ramp.
Capacity utilization & hot end mix — Himanshu Singh, Baroda BNP Paribas
AnsweredNo bottlenecking. Adding ₹450 Cr West India plant with 12-14% capacity increase. Hot end more profitable than cold end. Will increase hot end as % of product mix.
Commodity pass-through recovery — Shubham Agarwal, FIL
PartialOil main commodity hit. Some plastics, rubber. Mostly non-indexed, bifurcated into index and non-index. Index recoverable; non-index subject to OEM discussions. Geopolitical impact on forex also affecting.
Guidance
FY27 double-digit topline growth; FY2030 revenue fully covered by order book
HighOrder book ₹165K Cr. Prior guidance reaffirmed. Visible customer wins (OEMs) and program launches support growth.
Margin recovery expected long-term via DaVinci scale, localization, product mix
MediumNo specific margin target. Acknowledges near-term commodity pressure (oil, non-indexed items). Recovery timeline uncertain, depends on OEM pass-through negotiations.
FY27 capex ₹350-450 Cr supporting capacity expansion and localization
HighThree plants: North India Clean Air (SOP March 2027), West India Clean Air (SOP Sept 2027), ART suspension (SOP July 2027). Investment ₹450 Cr each for Clean Air.
Risks the call surfaced
Tariff & Geopolitical
HighTrump admin 100% tariff threat on India auto exports. Export order book fell ~50% YoY. OEM production delays and GDP contraction in Western markets slowing export business.
Margin Compression
HighOPM 15.2% vs stated EBITDA margin 17.2% on VAR. Oil, plastic, rubber cost increases. Most non-indexed; recovery depends on OEM negotiations. No timeline given.
Execution Risk
MediumNorth India plant SOP March 2027, West India Sept 2027, ART July 2027. Capex ₹450 Cr+ per plant. Risk: customer volumes don't ramp as planned, or mix shifts away from higher-margin products.
Technology Adoption
MediumDaVinci technology is still ramping. Semi-active suspension adoption competing with conventional. EV shift could reduce internal combustion vehicle suspension volumes.
Subsidiary Profitability
LowART (shock absorbers, suspension) margin compressed Q2 due to oil and commodity increases. Limited visibility into recovery timeline.
Management
Score 7/10. Clear on order book and growth strategy. But vague on FY2030 revenue target and margin recovery timeline. Avoids specific dividend policy. Met Q2 targets (₹1,718 Cr revenue +34% YoY, PAT ₹173 Cr +15% YoY). Capex ongoing as guided. Order book disclosure new and positive.
1 · Mar 2027
Northern India Clean Air facility SOP; ART suspension plant SOP (July)
2 · CY2027
US tariff policy resolution; Western OEM production recovery
3 · FY28+
DaVinci adoption scaling across OEM platforms; margin recovery via product mix
Key risk: export orders declining ~50% YoY due to tariff uncertainty and Western market slowdown.